BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27556305)

  • 1. Molecular dissection of the valproic acid effects on glioma cells.
    Hoja S; Schulze M; Rehli M; Proescholdt M; Herold-Mende C; Hau P; Riemenschneider MJ
    Oncotarget; 2016 Sep; 7(39):62989-63002. PubMed ID: 27556305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
    Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
    J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma.
    Proske J; Walter L; Bumes E; Hutterer M; Vollmann-Zwerenz A; Eyüpoglu IY; Savaskan NE; Seliger C; Hau P; Uhl M
    Anticancer Res; 2016 Mar; 36(3):899-905. PubMed ID: 26976976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
    Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
    Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.
    Hosein AN; Lim YC; Day B; Stringer B; Rose S; Head R; Cosgrove L; Sminia P; Fay M; Martin JH
    J Neurooncol; 2015 Apr; 122(2):263-71. PubMed ID: 25648357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma.
    Eckert M; Klumpp L; Huber SM
    Cell Physiol Biochem; 2017; 44(4):1591-1605. PubMed ID: 29212069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
    Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
    J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma.
    Watanabe S; Kuwabara Y; Suehiro S; Yamashita D; Tanaka M; Tanaka A; Ohue S; Araki H
    Eur J Clin Pharmacol; 2017 Mar; 73(3):357-363. PubMed ID: 27889835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
    Tseng JH; Chen CY; Chen PC; Hsiao SH; Fan CC; Liang YC; Chen CP
    Oncotarget; 2017 Feb; 8(9):14666-14679. PubMed ID: 28108734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation.
    Van Nifterik KA; Van den Berg J; Slotman BJ; Lafleur MV; Sminia P; Stalpers LJ
    J Neurooncol; 2012 Mar; 107(1):61-7. PubMed ID: 22037799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
    Krauze AV; Zhao Y; Li MC; Shih J; Jiang W; Tasci E; Cooley Zgela T; Sproull M; Mackey M; Shankavaram U; Tofilon P; Camphausen K
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.
    Pötschke R; Gielen G; Pietsch T; Kramm C; Klusmann JH; Hüttelmaier S; Kühnöl CD
    Pediatr Res; 2020 Mar; 87(4):669-676. PubMed ID: 31756732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines.
    Chang YL; Huang LC; Chen YC; Wang YW; Hueng DY; Huang SM
    Int J Biochem Cell Biol; 2017 Nov; 92():155-163. PubMed ID: 29017950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.
    Berendsen S; Broekman M; Seute T; Snijders T; van Es C; de Vos F; Regli L; Robe P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1391-415. PubMed ID: 22668241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor, 2-propylpentanoic acid, increases the chemosensitivity and radiosensitivity of human glioma cell lines in vitro.
    Shao CJ; Wu MW; Chen FR; Li C; Xia YF; Chen ZP
    Chin Med J (Engl); 2012 Dec; 125(24):4338-43. PubMed ID: 23253698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of valproic acid on the outcome of glioblastoma multiforme.
    Tsai HC; Wei KC; Tsai CN; Huang YC; Chen PY; Chen SM; Lu YJ; Lee ST
    Br J Neurosurg; 2012 Jun; 26(3):347-54. PubMed ID: 22168970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.
    Thotala D; Karvas RM; Engelbach JA; Garbow JR; Hallahan AN; DeWees TA; Laszlo A; Hallahan DE
    Oncotarget; 2015 Oct; 6(33):35004-22. PubMed ID: 26413814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.
    Papi A; Ferreri AM; Rocchi P; Guerra F; Orlandi M
    Anticancer Res; 2010 Feb; 30(2):535-40. PubMed ID: 20332466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.